A Prospective Cohort of Patients With Cervical/Intracranial Arteries Stenosis in China

NCT06595342 | Not Yet Recruiting DMC

• 1 other identifier: ARTERIES
• Study Type: observational
• Target: 60,000
• Locations: 1 country
• Sites: 1

Brief Summary

The aim of this study is to establish a prospective cohort of patients with cervical/intracranial arteries stenosis in China.

Conditions

Cervical Artery Stenosis; Intracranial Artery Stenosis

Keywords

Cervical Artery Stenosis; Intracranial Artery Stenosis

Outcome Measures

Primary Outcomes (1)

• Incidence of stroke

  Incidence of stroke events including ischemic stroke, transient ischaemic attack and haemorrhagic stroke.

  One year

Secondary Outcomes (2)

• Changes in the stenosis rate of cervical and intracranial arteries

  One year

• Incidence of new clinical vascular events

  One year

Study Arms (1)

Patients with cervical/intracranial arteries stenosis

Investigators plan to enroll 60000 patients with cervical/intracranial arteries stenosis including mild stenosis, moderate stenosis, severe stenosis or occlusion.

Other: No intervention

Interventions

No intervention OTHER

no intervention

Patients with cervical/intracranial arteries stenosis

Eligibility Criteria

• Age: 40 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients who were diagnosed with cervical artery stenosis and/or intracranial artery stenosis.

You may qualify if:

• Age ≥ 40 and ≤ 80 years;
• Ultrasound or imaging examinations indicating cervical artery stenosis and/or intracranial artery stenosis (including mild, moderate, severe stenosis, or occlusion);
• Willing to participate and signing the informed consent form.

You may not qualify if:

• Patients with stroke occurring within the past year;
• Patients with severe systemic diseases, such as respiratory failure, renal failure, gastrointestinal bleeding, coagulation disorders, malignancies, etc.;
• Patients with a life expectancy of less than one year or those who are unable to complete the study for other reasons.

Sponsors & Collaborators

• The First Hospital of Jilin University: lead

Study Sites (1)

First Hospital of Jilin University

Changchun, Jilin, 130000, China

Location

Central Study Contacts

Yi Yang, MD,PhD

CONTACT

13756661217; doctoryangyi@163.com

Zhen-Ni Guo, MD, PhD

CONTACT

18186872986; zhen1ni2@163.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: The associate deam

Study Record Dates

• First Submitted: September 10, 2024
• First Posted: September 19, 2024
• Study Start: October 30, 2024
• Primary Completion (Estimated): June 30, 2026
• Study Completion (Estimated): June 30, 2030
• Last Updated: October 3, 2024

Record last verified: 2024-10

Locations

CN (1)